B cells are the precursors of antibody-secreting cells. Since the frequency of B cells with receptors for a particular antigen is low, polyclonal stimuli have been used to study B cell activation. These stimuli include mitogens, such as lipopolysaccharide (LPS) 1, antibodies specific for surface immunoglobulin (sIg), and soluble factors from T cells. The results of studies with polyclonal activators suggest that activation of B cells from adult mice occurs in two stages: (a) the induction of proliferation by antiIg and T cell-derived B cell growth factor(s) (BCGF) (1-3), and (b) differentiation to Ig secretion by T cell-derived differentiation factors (BCDF) (4-8). Depending on the source of T cell-derived factors, the induction of IgM secretion may require concomitant cross-linking of Ig receptors by anti-Ig (7, 8) or can occur in the absence of antiIg (8-11). The lymphokine(s) in T cell supernatants (SN) that induces B cells to secrete IgM has been termed B cell differentiation factor(s) for IgM or BCDFu (8, 12) . In addition to BCDF~, we have defined a second lymphokine (BCDFy) that induces IgGa secretion by LPS-stimulated B cells (13) .
Materials and Methods
Animals. Adult BALB/e or (C57BL/6 × DBA/2) F1 (BDF1) (Cumberland Farms, Clinton, TN) mice were used at 8-20 wk of age. Neonates were bred in our colony and were used at 5-17 d of age.
BCLt Tumor. The BCLa tumor was maintained by in vivo passage in BALB/c mice.
Peripheral blood lymphocytes (PBL) were prepared from mice that carried the tumor for at least 8 wk. 90% or greater of PBL were tumor cells as determined by the expression of the BCL~ idiotype (14) .
Antibodies. Affinity-purified rabbit antibodies against mouse Ig (RAMIg), # (Rap), y (Ray), and 6 (RaS) heavy chains have been described (14, 15) . Goat anti-p and goat anti'-8 were prepared using the same immunogens. Sera were affinity purified, absorbed, and assayed as described (14) . Goat anti-ovalbumin was prepared by immunizing a goat with 1 mg of crystallized ovalbumin (OVA) in complete Freund's adjuvant. The goat was boosted at intervals and bled, and the pooled serum was affinity purified on Sepharose-OVA. Two monoclonal anti-Thy-1 antibodies were used (14) : the mouse IgM~-anti-Thy-l.2 product of the HO-13.4 hybridoma cells, obtained from the Cell Distribution Center of the Salk Institute, La Jolla, CA, and the rat IgG-anti-Thy-1 product of the HO-12.4 hybridoma cells, obtained from Dr. Noel Warner (Beeton Dickinson & Co., Palo Alto, CA). The rat anti-Lyt-1 and anti-Lyt-2 hybridomas (16) were obtained from the Cell Distribution Center of the Salk Institute. The purification of the monoelonal anti-Lyt-1 and anti-Lyt-2 antibodies has been described previously (8) . The rabbit antibodies were coupled to cyanogen-bromide-activated Sepharose-4B as previously described (17) .
Deletion of T Cells. T cells were removed by treatment of normal spleen cells or BCLI PBL
with monoclonal anti-Thy-1.2 (HO-13.4) and baby rabbit complement (C) (Pel-Freeze Biologicals, Inc., Rogers, AR). Alternatively, cells were treated with a cocktail of rat hybridoma antibodies directed against Thy-1 (HO-12.4), Lyt-1 (53.7.313), and Lyt-2 (52.6.72), followed by
RaT and C, as described (8) .
Culture Conditions. Normal B cells or BCLI PBL were cultured in flat-bottomed microtiter plates (Linbro Scientific Co., Hamden, CT) at 2-5 × l0 b cells/ml in Hepes-buffered RPMI 1640 supplemented with penicillin, streptomycin, and gentamycin (10 pg/ml), 50 pM 2-mercaptoethanol, and 10% fetal calf serum (FCS) (Grand Island Biological Co., Grand Island, NY). Cultures were incubated in an atmosphere of 83% N2, 10% CO2, 7% 02 at 37°C. BCGF Assay. B cell growth factor activity was detected by a modification of the method described by Howard et al. (1, 2) . Briefly, 2.5-5 × 105 B cells/ml were cultured in the presence of anti-/.t or anti-6 bound to Sepharose. T cell SN was added either immediately or after 24 h. On day 3, cultured cells were pulsed for 16 h with 1 ~Ci/culture [3H]thymidine, harvested, and counted.
Radioimmunoassay

T Cell SAT
T CELL LINES PK 7.1.1.A AND PK 7.1.2. Secondary alloreactive AKR anti-C57BL/6 (B6) cells (104/ml) were subcuhured weekly in the presence of irradiated (3,300 rad) B6 stimulator ceils I~ CELL GROWTH AND DIFFERENTIATION FACTORS (106/ml) in medium supplemented with rat spleen concanavalin A (Con A) SN as a source of interleukin 2 (IL-2) (20) . These cells have been maintained in culture for > 1.5 yr. The 7.1.2E8 and 7.1.2C7 cells are clones obtained by limiting dilution cloning of 7.1.2. Lymphokine release was induced (after washing the cells in IL-2-free medium containing 2% FCS) by pulsing the cells for 3 h with 10/zg/ml Con A, washing, and culturing for 24 h in medium lacking both IL-2 and Con A. Cells were removed by centrifugation and the cell-free SN was filtered, aliquoted, and stored at -70~C.
EL-4 TUMOR. EL-4 SN was prepared by stimulating 106 cells/ml of a cloned subline obtained from Dr. J. Farrar (National Institutes of Health) (21) with 20 nM phorbol myristate acetate (Sigma Chemical Co., St. Louis, MO). Cell-free SN were collected after 48 h, The SN was brought to 50% saturation with ammonium sulfate and the pellet was discarded. Lymphokines were then precipitated by bringing the SN to 85% saturation with (NH4)2SO4. The precipitate was dissolved in phosphate-buffered saline (PBS) (t0-20% of the original culture medium volume), dialyzed, and stored at -70°C.
B6. The B6 cell line was obtained by fusion of the FS6.14.13.AG2.1 cell line with T cells from spleen and lymph nodes of C57BL/10 mice as previously described (22) . Lymphokinecontaining SN were obtained by culturing B6 cells at 106 cells/ml with 4/zg/ml Con A for 24 h. SN containing c~-methylmannoside were tested along with control medium.
GEL VILTRATION ANALYSIS. Gel filtration analysis was performed on a 1 × 50-era column of Sephacryl-200 (S-200) (Pharmacia Fine Chemicals, Piscataway, N J). The sample of T cell SN was applied (maximum volume of 1 ml) and the material was eluted in PBS. 0.8-1-ml fractions were collected and the column fractions were brought to 5% (vol/vol) with FCS. Fractions were filter sterilized and tested for lymphokine activity.
Results
Definition of T Cell-derived B Cell Growth and Differentiation Factors. BCGF is defined
as a T cell-derived lymphokine that sustains anti-Ig-induced proliferation of B cells (1, 2) . The proliferative response of B cells from adult mice to anti-Ig alone is optimal on day 1 and falls to background levels by days 3-4 of culture. In the presence of BCGF, proliferation is sustained. Thus, the response is optimal on days 3-4 and is the same or greater than the response to anti-Ig alone at day 1.
BCDF~ is defined as a T cell-derived lymphokine that induces IgM secretion by either normal or neoplastic B cells (8) . BCDFv is defined as a lymphokine that induces IgG1 secretion in LPS-stimulated B cells (13) . SN were considered negative for each lymphokine if they exhibited <10% of the activity obtained with the reference SN 7.1.1a.
Presence of BCGF, BCDF~, or BCDF v in T Cell SN.
We first attempted to distinguish among BCGF, BCDF~ and BCDF v by analyzing the SN from different T cell lines and clones. Table I shows that SN from some T cell lines (e.g., SN from EL-4, 7.1.2 E8, and 7.1. la) contain all three lymphokines, whereas others (SN from B6 and 7.1.2 C7) contain only one. In addition, there was no correlation between the activity of BCGF, BCDF~, and BCDFv in different SN (data not shown). Taken together, these results suggest that the three lymphokine activities are carried by different molecules. Alternatively, SN lacking a particular lymphokine activity contain another lymphokine that suppresses the activity of the first lymphokine, so that the first lymphokine is not absent but rather suppressed. Distinguishing between these possibilities will only be possible when the lymphokines and/or suppressor factors have been purified.
Gel Filtration Analysis of BCGF, BCDF,, and BCDFy. SN from 7.1.2 was analyzed by gel filtration on a S-200 column, 1 ml of SN was chromatographed on a 1 × 50-cm column. 0.8 ml-fractions were collected and immediately supplemented to 5% (vol/ vol) with FCS. Each fraction was filter sterilized and assayed for lymphokines. As shown in Fig. 1 , this method separated BCDF~ from BCGF and BCDF r BCDF~ consistently eluted as two broad peaks averaging 30,000 and 60,000 mol wt, respectively. In contrast, BCDFr and BCGF could not be distinguished from each other since both eluted in broad peaks with apparent tool wt of <20,000. Similar results were obtained with SN from EL-4 and 7.1. la (data not shown).
To confirm the results obtained above, the column fractions from four different experiments were pooled and retested for BCDF~ and BCDF~. As shown in Fig. 2 , the pool of the fractions eluting at 30-60,000 mol wt had excellent BCDFu activity (A) and little or no BCDFy activity (B). In contrast, the pool of the fractions eluting at <20,000 mol wt had BCDFv activity (B) but no BCDF, activity (A). Thus, BCDF, is distinct from BCDFv. Some proliferation was observed when B cells from either adult or neonatal mice were treated with T cell SN alone (in the absence of anti-Ig). This response was particularly pronounced when using spleen cells from neonatal mice. To determine if this mitogenic response to SN alone was due to B cells, Ig + cells were deleted with anti-Ig and C before culture. The removal of sIg + cells did not change the mitogenic effect of T cell SN alone (Table II) . In contrast, the response to BCDF~ was reduced by at least 80% (data not shown). This indicates that B ceils had been effectively deleted by anti-Ig and C. We therefore conclude that the proliferative response induced by SN alone is not due to B cells in the culture. Since the 7.1 and EL-4 SN contain other lymphokines (such as CSF and MAF [20] ), background proliferation may be due to the effect of these lymphokines on other cells, e.g., hematopoietic progenitor cells and monocytes. 
Effect of BCGF on
Response of B Cells from Adult and Neonatal
Discussion
The data presented in this report suggest that BCGF, BCDF~, and BCDFy are three distinct lymphokines. This conclusion is based on three lines of evidence: (a) Each of the three lymphokines is present in some T cell SN but not others; (b) gel filtration distinguishes BCDF~ (30-60,000 mol wt) from BCGF/BCDFy (<20,000 mol wt); and (c) BCGF and BCDF show different target cell activities. Thus, both immature and mature B cells respond to BCDF~ and BCDF v. In contrast, B cells from neonatal mice are unresponsive to anti-Ig and BCGF, whereas adult B cells are highly responsive. These observations support the notion that BCGF is distinct from both types of BCDF and that BCDF~ and BCDF v are different from each other. The biological and biochemical properties of the three lymphokines are summarized in Table III .
Several other T cell-derived lymphokines that induce polyclonal B cell growth and differentiation have been described (4, 5, (9) (10) (11) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) . This family of lymphokines has been referred to as B cell stimulating factors (BCSF) (34) . BCSF include T cell replacing factor (TRF) (4, 5) , allogeneic effect factor (AEF) (29, 30) , BCGF (1, 2, 31, 33), BCDF (8, 13) , and B cell replication and maturation factors (BRMF) (11) . These factors are all defined by their ability to induce growth and/or differentiation of normal or neoplastic B cells. The relationship of these lymphokines to one another is unknown.
At least two lymphokines (AEF and TRF) that induce differentiation to IgM and IgG secretion may be different from BCDF. In contrast to BCDFy (unpublished results), AEF exhibits H-2 restriction (35). However, since AEF has not been evaluated using LPS-stimulated cells, it is not possible to formally exclude the possibility that (5, 20) , BCGF, BCDF,, and BCDF~ must be different from TRF.
Lymphokines that induce B cell proliferation include BCGF and BRMF. BCGF is defined by its ability to sustain the proliferation of anti-Ig (1, 2) or mitogen-stimulated (33) B cells. Other lymphokines that sustain replication of slowly dividing B cells in the absence of other signals (e.g., anti-Ig) may exist and may be different from the BCGF as defined by others (1, 2, 31, 33) and ourselves in this study. BRMF (11) induces both growth and maturation of B cells in the presence of histoincompatible adherent cells and antigen. However, maturation occurs in both resting B cells and B cell blasts, whereas growth occurs only in B cell blasts (11) . It is therefore possible that BRMF contains both BCGF and BCDF,.
Two lymphokines that induce the secretion of isotypes other than IgM have been described: (a) a lymphokine that specifically binds to IgE and induces IgE secretion by antigen-activated B cells (37) , and (b) a tymphokine that induces IgG1 secretion by sIgG-negative, LPS-stimulated B cells (BCDF 0 (13) . The existence of T cell subsets that induce the secretion of particular isotypes (38) (39) (40) The inability of neonatal B cells to proliferate in response to anti-Ig and BCGF is consistent with their inability to proliferate in response to LPS despite the fact that LPS induces immature B cells to secrete all isotypes of Ig (43) . Neonatal B cells are relatively immunoincompetent to challenge with specific antigen. Our results might partially explain this incompetence by suggesting that neonatal B cells terminally differentiate in the absence of clonal expansion, and thus yield a poor antibody response. The implications of these findings for the ease of susceptibility to tolerance induction of immature as opposed to mature B cells (44, 45) is unclear. However, it is conceivable that terminal differentiation in the absence of ctonal expansion is one mechanism for putative B cell tolerance as originally suggested by Sterzl and Trnka (46) . If this were the case, one might postulate the existence of a suppressor mechanism in adult bone marrow or neonatal spleen that prevents the in situ terminal differentiation of clones of immature B cells reactive with foreign antigens. Alternatively, central lymphoid tissues might lack BCDF-producing T cells. In this regard, a number of laboratories have described suppressor monoeytes in the bone marrow (47, 48) and neonatal spleen (49) that prevent antibody responses of normal B cells in vitro. It is possible that these suppressor cells exert their effect via the suppression of BCDF and prevent immature B cells from terminally differentiating.
Summary
In these studies we have determined the molecular weights of B cell growth factor (BCGF) (<20,000), and B cell differentiation factors (BCDF) that induce immunoglobulin M (IgM) secretion (BCDF~) (30-60,000) and IgG secretion (BCDFv) (<20,000). Thus, the molecular weight of BCDFv is distinct from that of BCGF and BCDFv; BCGF and BCDFv cannot be distinguished. In addition, BCGF, BCDFu, and BCDFy are distinguishable by their presence or absence in different supernatants from a panel of mitogen-induced T cell clones. These results suggest that the three lymphokines are different. 
